Vedolizumab for induction and maintenance of remission in Crohn's disease.

ABSTRACT:

SUBMITTER: Hui S 

PROVIDER: S-EPMC10351211 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature